Scientists are edging closer to developing blood tests that could detect early stage cancer, before patients show any symptoms of the disease.One such test, called PanSeer, can potentially spot five types of cancers up to four years earlier than current diagnostic methods, according to a study published Tuesday in the journal Nature Communications.The test works…
If the government is not transparent, the public could stop participating in measures to prevent the spreading of the virus, one scientist says.At least one member of the Ministerial Advisory Committee says advisories prepared for the government should remain confidential.There are doubts whether the advisories are ever "taken forward" for discussion in higher government structures.Health…
Scientists identify six different 'types' of Covid-19 each based on 'cluster of symptoms' which will help monitor those must vulnerable to catching itData suggests coronavirus comes in several forms, each with symptom clustersKing's College London's Symptom Study app findings could help the vulnerableContinuous cough, fever and loss of smell are the three main Covid-19 symptomsBy…
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.